Perioperative use of levosimendan: Best practice in operative settings

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 27, Issue 2, 2013, Pages 361-366

  Toller, Wolfgang ^a   Algotsson, Lars ^b   Guarracino, Fabio ^c   Hörmann, Christoph ^d   Knotzer, Johann ^e   Lehmann, Andreas ^f   Rajek, Angela ^g   Salmenperä, Markku ^h   Schirmer, Uwe ⁱ   Tritapepe, Luigi ^j   Weis, Florian ^k   Landoni, Giovanni ^l,m  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^e Klinikum Wels Grieskirchen GmbH   (Austria)

^f KLINIKUM LUDWIGSHAFEN   (Germany)

^g UNIVERSITY OF VIENNA   (Austria)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^m Maieutics Foundation   (Italy)

more..

Author keywords

anesthesia; cardiac surgery; cardioprotection; consensus guidelines; hemodynamic; inodilator; intensive care; levosimendan

Indexed keywords

CARVEDILOL; CATECHOLAMINE; DOBUTAMINE; ESMOLOL; LEVOSIMENDAN; MILRINONE; N [4 (1,4,5,6 TETRAHYDRO 4 METHYL 6 OXO 3 PYRIDAZINYL)PHENYL]ACETAMIDE; NORADRENALIN; PLACEBO; POTASSIUM CHANNEL;

ABDOMINAL SURGERY; ADD ON THERAPY; AMBULATORY CARE; ANESTHESIA INDUCTION; APOPTOSIS; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CLINICAL PRACTICE; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; DRUG ACCUMULATION; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; EVIDENCE BASED MEDICINE; FORWARD HEART FAILURE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART PROTECTION; HEART VENTRICLE REMODELING; HIGH RISK PATIENT; HIP SURGERY; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE; INTRAOPERATIVE PERIOD; KIDNEY FUNCTION; LENGTH OF STAY; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; VASODILATATION;

CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; CRITICAL ILLNESS; HUMANS; HYDRAZONES; PERIOPERATIVE CARE; PYRIDAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL PROCEDURES, OPERATIVE;

EID: 84875221905     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2012.04.007     Document Type: Review

References (70)

1. G. Landoni, G. Biondi-Zoccai, M. Greco Effects of levosimendan on mortality and hospitalization A meta-analysis of randomized controlled studies Crit Care Med 40 2012 634 646
2. Z. Papp, I. Edes, S. Fruhwald Levosimendan: Molecular mechanisms and clinical implications consensus of experts on the mechanisms of action of levosimendan Int J Cardiol 2012 [Epub ahead of print]
3. N. Erdei, Z. Papp, P. Pollesello The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles Br J Pharmacol 148 2006 696 702
4. S. Szilágyi, P. Pollesello, J. Levijoki The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig Eur J Pharmacol 486 2004 67 74
5. J. Lilleberg, M. Laine, T. Palkama Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure Eur J Heart Fail 9 2007 75 82
6. G. Landoni, J.G. Augoustides, F. Guarracino Mortality reduction in cardiac anesthesia and intensive care: Results of the First International Consensus Conference Acta Anaesthesiol Scand 55 2011 259 266
7. B. Akselrod, N. Trekova, I. Tolstova Preoperative levosimendan administration: What is the vascular payment during anaesthesia? J Cardiothorac Vasc Anesth 24 2010 S18
8. E. Al-Shawaf, A. Ayed, I. Vislocky Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery J Cardiothorac Vasc Anesth 20 2006 353 357
9. J. Alvarez, M. Bouzada, A.L. Fernández [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery] Rev Esp Cardiol 59 2006 338 345
10. J. Alvarez, M. Taboada, J. Rodríguez [Hemodynamic effects of levosimendan following cardiac surgery] Rev Esp Anestesiol Reanim 52 2005 389 394
11. S. Barisin, I. Husedzinovic, Sonick Levosimendan in off-pump coronary artery bypass: A four-times masked controlled study J Cardiovasc Pharmacol 44 2004 703 708
12. C. Chamos, T. Daidou, E. Delis The effects of levosimendan compared with milrinone in cardiac surgery patients J Cardiothorac Vasc Anesth 29 2009 S19
13. S.G. De Hert, S. Lorsomradee, S. Cromheecke The effects of levosimendan in cardiac surgery patients with poor left ventricular function Anesth Analg 104 2007 766 773
14. H.I. Eriksson, J.R. Jalonen, L.O. Heikkinen Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function Ann Thorac Surg 87 2009 448 454
15. I. Husedzinović, S. Barisin, N. Bradić Levosimendan as a new strategy during off-pump coronary artery bypass grafting: Double-blind randomized placebo-controlled trial Croat Med J 46 2005 950 956
16. K. Järvelä, P. Maaranen, T. Sisto Levosimendan in aortic valve surgery: Cardiac performance and recovery J Cardiothorac Vasc Anesth 22 2008 693 698
17. K. Jörgensen, O. Bech-Hanssen, E. Houltz Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis Circulation 117 2008 1075 1081
18. I. Knez, S. Schweiger, I. Ovcina Effects of Ca2+ sensitiser levosimendan on flow in internal thoracic and radial arteries in patients undergoing CABG - Preliminary results Eur Heart J 26 abstr P3129 2005 527
19. P. Lahtinen, O. Pitkänen, P. Pölönen Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial Crit Care Med 39 2011 2263 2270
20. 2 gradient in abdominal aortic aneurysm surgery Acta Anaesthesiol Scand 52 2008 785 792
21. H. Leppikangas, K. Järvelä, T. Sisto Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery Br J Anaesth 106 2011 298 304
22. R.L. Levin, M.A. Degrange, R. Porcile [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome] Rev Esp Cardiol 61 2008 471 479
23. R. Levin, M. Degrange, C. Del-Mazo Superiority of levosimendan over dobutamine in low cardiac output syndrome after aortic valve replacement Circulation 118 2008 E231
24. R. Levin, M. Degrange, R. Porcile Preoperative use of calcium sensitizer levosimendan reduces mortality and low cardiac output syndrome in patients with aortic stenosis and left ventricular dysfunction Circulation 118 2008 E217
25. R. Levin, R. Porcilem, F. Salvagio Levosimendan reduces mortality in postoperative low cardiac output syndrome after coronary surgery J Clin Exp Cardiol 2012 [Epub ahead of print]
26. J. Lilleberg, M.S. Nieminen, J. Akkila Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting Eur Heart J 19 1998 660 668
27. N. Nijhawan, A.C. Nicolosi, M.W. Montgomery Levosimendan enhances cardiac performance after cardiopulmonary bypass: A prospective, randomized placebo-controlled trial J Cardiovasc Pharmacol 34 1999 219 228
28. L. Tritapepe, V. De Santis, D. Vitale Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery Br J Anaesth 102 2009 198 204
29. L. Tritapepe, V. De Santis, D. Vitale Preconditioning effects of levosimendan in coronary artery bypass grafting - A pilot study Br J Anaest 96 2006 694 700
30. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
31. M.B. Yilmaz, K. Yalta, C. Yontar Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine Cardiovasc Drugs Ther 21 2007 431 435
32. J. Puttonen, S. Kantele, M. Kivikko Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites Clin Pharmacokinet 46 2007 235 246
33. V.V. Lomivorotov, V.A. Boboshko, S.M. Efremov Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients J Cardiothorac Vasc Anesth 2011 [Epub ahead of print]
34. L. Severi, A. Lappa, G. Landoni Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients J Cardiothorac Vasc Anesth 25 2011 632 636
35. S. Sponga, E. Ivanitskaia, E. Potapov Preoperative treatment with levosimendan in candidates for mechanical circulatory support ASAIO J 58 2012 6 11
36. F. Guarracino, G. Landoni, R. Baldassarri Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock Br J Anaesth 104 2010 388 389
37. J.A. Alhashemi Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists Br J Anaesth 95 2005 648 650
38. D. Barraud, V. Faivre, T. Damy Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: Comparison with dobutamine and milrinone Crit Care Med 35 2007 1376 1382
39. H. Haikala, J. Levijoki, I.B. Lindén Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension J Mol Cell Cardiol 27 1995 2155 2165
40. M. Ponschab, N. Hochmair, N. Ghazwinian Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair Eur J Anaesthesiol 25 2008 627 633
41. O. Ersoy, A.B. Budak, U. Mungan Levosimendan for ischemic preconditioning in thoracic aortic aneurysm repair J Cardiovasc Surg 23 2008 251 253
42. S. Katsaragakis, A. Kapralou, P. Drimousis Prophylactic preoperative levosimendan administration in heart failure patients undergoing elective non-cardiac surgery: A preliminary report Hellenic J Cardiol 50 2009 185 192
43. S. Katsaragakis, A. Kapralou, H. Markogiannakis Preoperative levosimendan in heart failure patients undergoing noncardiac surgery Neth J Med 66 2008 154 159
44. A. Mebazaa, M.S. Nieminen, G.S. Filippatos Levosimendan vs. dobutamine: Outcomes for acute heart failure patients on beta-blockers in SURVIVE Eur J Heart Fail 11 2009 304 311
45. J.N. Nanas, P. Papazoglou, E.P. Tsagalou Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone Am J Cardiol 95 2005 768 771
46. S. Mavrogeni, G. Giamouzis, E. Papadopoulou A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure J Card Fail 13 2007 556 559
47. N.M. Parle, M.D. Thomas, L. Dembo Repeated infusions of levosimendan: Well tolerated and improves functional capacity in decompensated heart failure - A single-centre experience Heart Lung Circ 17 2008 206 210
48. J.T. Parissis, S. Adamopoulos, D. Farmakis Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure Heart 92 2006 1768 1772
49. F.X. Kleber, T. Bollmann, M.M. Borst Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: Results of a pilot study J Clin Pharmacol 49 2009 109 115
50. J. Altenberger, J.T. Parissis, H. Ulmer Rationale and design of the multicentre randomized trial investigating the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep study) Eur J Heart Fail 12 2010 186 192
51. A. Beiras-Fernandez, F. Kur, I. Kaczmarek Levosimendan for primary graft failure after heart transplantation: A 3-year follow-up Transplant Proc 43 2011 2260 2262
52. K. Brixius, S. Reicke, R.H. Schwinger Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium Am J Physiol Heart Circ Physiol 282 2002 H131 H137
53. A. Morelli, J.L. Teboul, S.M. Maggiore Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study Crit Care Med 34 2006 2287 2293
54. B.B. Pinto, S. Rehberg, C. Ertmer Role of levosimendan in sepsis and septic shock Curr Opin Anaesthesiol 21 2008 168 177
55. A. Morelli, S. De Castro, J.L. Teboul Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression Intensive Care Med 31 2005 638 644
56. L. Padayachee Levosimendan: The inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy? Heart Lung Circ 16 suppl 3 2007 S65 S70
57. M. Antonini, G.V. Stazi, M.T. Cirasa Efficacy of levosimendan in takotsubo-related cardiogenic shock Acta Anaesthesiol Scand 54 2010 119 120
58. V. De Santis, D. Vitale, L. Tritapepe Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome Ann Intern Med 149 2008 365 367
59. P. Namachivayam, D.S. Crossland, W.W. Butt Early experience with levosimendan in children with ventricular dysfunction Pediatr Crit Care Med 7 2006 445 448
60. P.K. Suominen Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure BMC Anesthesiol 11 2011 18-18
61. W.A. Osthaus, D. Boethig, M. Winterhalter First experiences with intraoperative levosimendan in pediatric cardiac surgery Eur J Pediatr 168 2009 735 740
62. E. Lechner, W. Moosbauer, M. Pinter Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate Pediatr Crit Care Med 8 2007 61 63
63. M. Sterba, A. Banerjee, Y. Mudaliar Prospective observational study of levosimendan and weaning of difficult-to-wean ventilator dependent intensive care patients Crit Care Resusc 10 2008 182 186
64. L. Ouanes-Besbes, I. Ouanes, F. Dachraoui Weaning difficult-to-wean chronic obstructive pulmonary disease patients: A pilot study comparing initial hemodynamic effects of levosimendan and dobutamine J Crit Care 26 2011 15 21
65. K. Siirilä-Waris, R. Suojaranta-Ylinen, V.P. Harjola Levosimendan in cardiac surgery J Cardiothorac Vasc Anesth 19 2005 345 349
66. J. Doorduin, C.A. Sinderby, J. Beck The calcium sensitizer levosimendan improves human diaphragm function Am J Respir Crit Care Med 185 2012 90 95
67. C.L. Tacon, J. McCaffrey, A. Delaney Dobutamine for patients with severe heart failure: A systematic review and meta-analysis of randomised controlled trials Intensive Care Med 38 2012 359 367
68. S. Thackray, J. Easthaugh, N. Freemantle The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis Eur J Heart Fail 4 2002 515 529
69. M. Packer, J.R. Carver, R.J. Rodeheffer Effect of oral milrinone on mortality in severe chronic heart failure The PROMISE Study Research Group N Engl J Med 325 1991 1468 1475
70. M.S. Nieminen, P. Pollesello, G. Vajda Effects of levosimendan on the energy balance: Preclinical and clinical evidence J Cardiovasc Pharmacol 53 2009 302 310